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license (http://creativecommons.org/Summary Background/Objective: We have previously shown that an extracellular matrix
(ECM) bioscaffold derived from porcine small intestine submucosa (SIS) enhanced the healing
of a gap injury of themedial collateral ligament as well as the central third defect of the patellar
tendon. With the addition of a hydrogel form of SIS, we found that a transected goat anterior
cruciate ligament (ACL) could also be healed. The result begs the research question of whether
SIS hydrogel has positive effects on ACL fibroblasts (ACLFs) and thus facilitates ACL healing.
Methods: In the study, ECM-SIS hydrogel was fabricated from the digestion of decellularised and
sterilised sheets of SIS derived from aGal-deficient (GalSafe) pigs. As a comparison, a pure
collagen hydrogel was also fabricated from commercial collagen type I solution. The morpho-
metrics of hydrogels was assessed with scanning electron microscopy. The ECM-SIS and collagen
hydrogels had similar fibre diameters (0.105 0.010 mm vs. 0.114 0.004 mm), fibre orientation
(0.51  0.02 vs. 0.52  0.02), and pore size (0.092  0.012 mm vs. 0.087  0.008 mm). The pres-
ervation of bioactive properties of SIS hydrogel was assessed by detecting bioactive molecules
sensitive to processing and enzyme digestion, such as growth factors fibroblast growth factor-
2 (FGF-2) and transforming growth factor-beta 1 (TGF-b1), with enzyme-linked immunosorbent
assay. ACLFs were isolated and expanded in culture from explants of rat ACLs (nZ 3). The cells
were then seeded on the hydrogels and cultured with 0%, 1%, and 10% foetal bovine serum (FBS)
for 3 days and 7 days. Cell attachment was observed using a light microscope and scanning elec-
tron microscopy, whereas cell proliferation and matrix production (collagen types I and III) were
examined with bromodeoxyuridine assays and reverse transcription-polymerase chain reaction,
respectively.letal Research Center, Department of Bioengineering, Swanson School of Engineering, University of
ring, 300 Technology Drive, Pittsburgh, PA 15219, USA.
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Effects of an ECM hydrogel on ACL fibroblast 115Results: The results showed that FGF-2 and TGF-b1 in the SIS hydrogel were preserved by 50%
(65.9  26.1 ng/g dry SIS) and 90% (4.4  0.6 ng/g dry SIS) relative to their contents in ECM-
SIS sheets, respectively. At Day 3 of culture, ACLFs on the SIS hydrogel were found to proliferate
39%, 31%, and 22%more than those on the pure collagen hydrogel at 0%, 1%, and 10% FBS, respec-
tively (p < 0.05). Collagen type I mRNA expression was increased by 150%, 207%, and 100%,
respectively, compared to collagen hydrogel (p< 0.05), whereas collagen type III mRNA expres-
sion was increased by 123% and 132% at 0% and 1% FBS, respectively (all p < 0.05) but not at 10%
FBS. By Day 7, collagen type I mRNA expression was still elevated by 137% and 100% compared to
collagen hydrogel at 1% and 10% FBS, respectively (p < 0.05). Yet, collagen type III mRNA levels
were not significantly different between the two groups at any FBS concentrations.
Conclusion: Our data showed that the ECM-SIS hydrogel not only supported the growth of ACLFs,
but also promoted their proliferation and matrix production relative to a pure collagen hydro-
gel. As such, ECM-SIS hydrogel has potential therapeutic value to facilitate ACL healing at the
early stage after injury.
Copyrightª 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The anterior cruciate ligament (ACL) in the knee joint is an
important structure to maintain knee stability. Unlike extra-
articular ligaments such as the medial collateral ligament,
which have a high propensity for healing even without sur-
gical management [1,2], the ACL has a limited capability to
heal once injured, and the outcomes of nonsurgical man-
agement of its midsubstance rupture have been poor [3,4].
The literature has attributed the causes to detrimental
factors such as high residual strain resulting in a significant
retraction of ruptured ends that left a large gap between
the torn ends, relative poor circulation making it difficult to
form localized hematoma to bridge the gap, as well as lower
activity of ACL fibroblasts (ACLFs) [5e10]. Although surgical
reconstruction using soft-tissue autografts/allografts has
been the major treatment regimen to restore knee stability,
graft-associated complications are not uncommon, result-
ing in a high rate of less-than-satisfactory outcomes in the
long term [11e13]. With the advancements in functional
tissue engineering, various strategies have been vigorously
investigated in order to improve the healing of ACL with
minimal surgical interference.
Extracellular matrix (ECM) bioscaffolds, such as those
derived from the porcine small intestine submucosa (SIS),
have been successfully used in a number of clinical applica-
tions to accelerate healing and repair of hernia and injuries
in other soft connective tissues [14e16]. They have also been
approved by the Food and Drug Administration for urethral
reconstruction, pelvic prolapse, soft tissue repair (both
connective and cardiac), etc. [17]. In our research centre,
we have shown that ECM-SIS enhanced the healing of a
central third defect of the patellar tendon after it was har-
vested as an autograft for ACL reconstruction. Furthermore,
ECM-SIS improved the healing of a 6-mm-wide gap of a torn
medial collateral ligament and, more importantly, improved
the mechanical properties of the neoligament [18e21].
Recently, methods have become available to create a
hydrogel form of the ECM that can be injected to fill a
wound in situ [22]. These ECM hydrogels have shown the
potential to promote regeneration of various tissues andorgans ranging from bone to central nervous system
[23,24]. In an in vivo animal study, porcine ECM-SIS hydro-
gel in conjunction with a sheet form of ECM-SIS has been
successfully used to heal a surgically transected ACL in a
goat model [25]. The structural properties of the healing
femureACLetibia complex with this treatment compared
favourably to those of the ACL reconstruction [26,27],
which demonstrated that therapy with ECM bioscaffolds
can potentially be an alternative to ACL reconstruction in
the clinical arena.
Previous studies revealed that the extracts from ECM-SIS
have positive bioactive effects on the cellular activities of
the healing ACLFs, such as increased cell proliferation [28].
Even the degradation products of an ECM (prehydrogel so-
lution after enzyme digestion) have been shown to possess
chemotactic and mitogenic effects [29]. As the major cell
population residing in the ligament, the fibroblasts are
critical in orchestrating the healing response when a liga-
ment is injured (e.g., by shifting phenotypes) and helping
restore the continuity and function of ligaments by active
synthesis and remodelling of the matrix [6e8]. Thus, the
research question was whether the SIS hydrogel has pro-
moting effects on the activity of ACLFs including cell pro-
liferation and matrix formation, and thus the potential to
facilitate ACL healing. If so, the hydrogel would be a
desirable scaffold material for ACL healing because of its
ease of administration through injections and its ability to
fill irregular shapes and gaps. We hypothesised that the
bioactive ECM-SIS hydrogel [17] can enhance ACLFs to
proliferate as well as to produce more collagen and thus has
the potential to improve ACL healing.
To test our hypothesis, we performed in vitro experi-
ments using ACLFs derived from the rat. For comparison,
we used a pure collagen type I hydrogel so that the
potential advantages of ECM hydrogels can be elucidated.
We also studied the possible loss of bioactive molecules
from the ECM-SIS sheet in the hydrogel preparation by
quantifying growth factors that are sensitive to material
processing and enzyme digestion. Two of the most abun-
dant growth factors in ECM-SIS (fibroblast growth factor-2
(FGF-2) and transforming growth factor-beta 1 (TGF-b1))
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study [28]. The ACLFs were cultured on hydrogels for 3 days
and 7 days at low and high levels of concentration of foetal
bovine serum (FBS). The different concentrations of FBS
were chosen to test whether the effects of ECM-hydrogel on
ACLFs would be impacted when the blood supply to a
ruptured ACL varies [5,6,9]. The cell proliferation and gene
expressions of collagen matrix were examined and
compared.
Materials and methods
Hydrogel preparation
The small intestine from an aGal-deficient pig (GalSafe;
w13 months, 180 kg) was obtained from Revivicor Inc.
(Blacksburg, VA, USA). These aGal-deficient (aGal())
transgenic pigs have been engineered to be free of aGal
epitope, which has been linked to acute rejection of
xenogenic implants [30]. Previously, we have obtained the
ECM-SIS from these transgenic pigs and confirmed that
growth factors, such as FGF-2, TGF-b1, vascular endothelial
growth factor (VEGF), and platelet-derived growth factor
BB (PDGF-BB), were present in the aGal-deficient ECM-SIS
sheets, and their levels were comparable to those derived
from the wild-type ECM-SIS [28].
Sheets of the ECM-SIS were obtained using a previously
described method [22,25]. The small intestine was first
manually cleaned. The aGal() SIS (tunica submucosa and
basilar portion of the tunica mucosa) was separated from
the whole intestine and decellularised in a 0.1% peracetic
acid/4% ethanol solution, rinsed twice each in phosphate-
buffered saline (PBS) and deionized water, and lyophi-
lised. The ECM-SIS sheets were then sterilized with ethylene
oxide and comminuted to a powder using a Wiley Mini Mill
(Thomas Scientific, Swedesboro, NJ, USA) with a size 40
mesh to produce particles of an optimal size for digestion
[31]. One gram of the SIS powder and 50 mg of pepsin
(Sigma, St. Louis, MO, USA;w2000e2300 U/mg) were added
to 100 mL of 0.01M HCl and stirred for 48 hours at room
temperature. The resultant solution (Figure 1A) of digested
SIS (10 mg/mL) was kept frozen at 20C until used.
To make the ECM-SIS hydrogel, the digested SIS solution
was diluted with 1  PBS to 6 mg/mL from the initial con-
centration of 10mg/mL, and the pHwas adjusted to 7.4 with
0.1N NaOH. The final mixture was incubated at 37C for 1
hour to form a hydrogel. A pure collagen hydrogel (3.2 mg/
mL; Inamed Biomaterials, Fremont, CA, USA) was prepared
as per the manufacturer’s instructions and served as a
comparison in the experiments. Eight parts of the purified
collagen solution were mixed with 1 part of 10 PBS. The
solution’s pH was adjusted to 7.4 using 0.1M NaOH. One part
of deionisedwater was added, and the resulting solution was
incubated at 37C for 90 minutes (see Figure 1B).
Scanning electron microscopy and microscopic
morphology
The morphology of the SIS and pure collagen hydrogels was
then studied using scanning electron microscopy (SEM) as
previously described [31]. After fixing with 2.5%glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA,
USA) at 4C for 24 hours, a series of washes in 1  PBS and
dehydrations in 30%, 50%, 70%, 90%, and 100% ethanol were
performed. The hydrogels were cut to 2 mm  2 mm pieces
and dried using a Critical Point Dryer (Leica EM CPD030;
Leica Microsystems, Buffalo Grove, IL, USA) and coated
with a 4.5-nm-thick gold/palladium alloy using a sputter
coater (108 Auto; Cressington Scientific Instruments, Wat-
ford, UK). Five samples were imaged with a scanning
electron microscope (JSM 6330F; JEOL, Peabody, MA, USA),
and micrographs were taken. The micrographs were then
analyzed using a customized Matlab software as described
previously [32] to obtain fibre diameter and orientation,
porosity, and pore size.
Quantification of growth factors with enzyme-
linked immunosorbent assay
To determine if the growth factors were still present in the
ECM-SIS hydrogel after the processing and enzyme digestion,
FGF-2 and TGF-b1, the two most abundant growth factors in
the sheet form of ECM-SIS [28], were quantified through
enzyme-linked immunosorbent assay. Briefly, 1 mL of the SIS
digest (10 mg dry SIS) was mixed with 1 mL of PBS to dilute
the digest because of its high viscosity. With the diluted
digests, enzyme-linked immunosorbent assay solid-phase
detection kits for FGF-2 (Quantikine DFB50; R&D Systems,
Minneapolis, MN, USA) and TGF-b1 (QuantikineDB100B; R&D
Systems) were used as per the manufacturers’ instructions.
The optical density at 450 nm, with a reference wavelength
at 540 nm, was measured using a microplate reader (Infinite
M200; Tecan, Morrisville, NC, USA).
ACLF isolation and culture
Rat ACLFs were harvested from the ACLs of rats (Sprague
Dawley from Charles River, 3 to 4 months, male; n Z 3)
humanely euthanised as outlined and approved by the
University of Pittsburgh Institutional Animal Care and Use
Committee. From these primary cell lines, third-passage
cells were used in all experiments. For the cell prolifera-
tion and gene expression experiments, we used 0%, 1%, and
10% FBS to examine the effects of ECM-SIS hydrogel on the
behaviours of ACLFs, and thus to estimate the function of
hydrogel when the bloody supply to the injured ACL varies
[5,33].
Cell attachment observation and cell proliferation
assay with bromodeoxyuridine incorporation
ACLFs from different rats (nZ 3) were separately cultured
on the surface of the SIS hydrogel (n Z 3) and the pure
collagen hydrogel (nZ 3) in 96-well plates at 105 cells/well
with Dulbecco’s modified Eagle’s medium and the different
concentrations of FBS described above for 3 days and 7
days. In addition, for the purpose of SEM study, 2  106
cells/well were seeded on both hydrogels with 10% FBS in
Dulbecco’s modified Eagle’s medium in six-well plates for 3
days. Cell attachment and morphology were observed with
light microscopy and SEM at Day 3. For the cell proliferation
assay, a bromodeoxyuridine (BrdU) incorporation assay
Figure 1 (A) Appearance of solutions for making ECM-SIS hydrogel and pure collagen hydrogel prior to gelation. (B) Appearance of
SIS hydrogel and pure collagen hydrogel after gelation. (C). Electron micrograph of SIS hydrogel. (D) Electron micrograph of pure
collagen hydrogel showing fibre morphology. ECM Z extracellular matrix; SIS Z small intestine submucosa.
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sure cell proliferation as previously described [28]. Briefly,
after incubation for 4 hours with BrdU, collagenase was
added for hydrogel digestion. Cells were isolated through
centrifugation and followed by incubation with anti-BrdU
antibodies for BrdU detection. The plate was read on a
microplate reader (Infinite M200; Tecan) with excitation at
325 nm and emission at 420 nm.
Collagen type I and III gene expressions with
reverse transcription-polymerase chain reaction
ACLFs from different rats (n Z 3) embedded in 2 mL SIS
hydrogel (n Z 3) and pure collagen hydrogel (n Z 3) were
cultured on six-well plates at 2  106 cells/well with cul-
ture medium for 3 days and 7 days with the three different
concentrations of FBS. The ACLFs were isolated through
collagenase treatment of the cellehydrogel mixtures. The
RNAs were then extracted using TriZol Reagent (Invitrogen,Table 1 Primer sequences used in the study for mRNA quantifi
Gene Sequence
Collagen type I 50-TCA CCT ACA GCA CGC TTG-3
50-GGT CTG TTT CCA GGG TTG-
Collagen type III 50-ATA TCA AAC ACG CAA GGC-3
50-GAT TAA AGC AAG AGG AAC A
TGF-b1 50-TGC TAA TGG TGG ACC G-30
50-ACG TCA AAA GAC AGC C-30
GAPDH 50-ACA TCA TCC CTG CAT CCA C
50-GGG AGT TGC TGT TGA AGT
ACLFsZ anterior cruciate ligament fibroblasts; GAPDHZ glyceraldeh
polymerase chain reaction; TGF-b1 Z transforming growth factor-b1.Carlsbad, CA, USA). Reverse transcription-polymerase chain
reaction was performed as previously described [34]. Levels
of mRNA for collagen type I, collagen type III, and a
housekeeping gene, glyceradehyde-3-phosphate dehydro-
genase (GAPDH; n Z 3), were measured using an Opticon
System Thermal Cycler (MJ Research, Waltham, MA, USA).
The primer sequences are presented in Table 1. The cDNA
amount (R) of each gene was calculated and normalized to
that of GAPDH [35].
Data analysis
For statistical analysis, an independent t test was per-
formed on fibre diameter, fibre orientation, pore size, and
porosity obtained from SEM images. Significance was set at
p < 0.05. On the effect of hydrogel type (SIS hydrogel vs.
pure collagen hydrogel) on cell proliferation, a three-way
analysis of variance (ANOVA) was first done to test the in-
teractions between FBS concentration (0%, 1%, and 10%)cation with RT-PCR in rat ACLFs.
Annealing
temperature (C)
Refs.
0
30
55 [45]
0
C-30
52 [45]
52 [46]
T-30
CA-30
55 [45]
yde-3-phosphate dehydrogenase; RT-PCRZ reverse transcription-
118 R. Liang et al.and culture period (3 days and 7 days). Then t tests were
performed at each FBS concentration or between time
points to determine whether there were statistically sig-
nificant differences. The same procedure was repeated for
collagen type I mRNA expression and collagen type III mRNA
expression.
Results
SEM and microscopic morphology
Electron micrographs revealed similar fibre morphologies
for ECM-SIS and pure collagen hydrogels (Figures 1C and
1D). Quantitative image analysis [32] further confirmed this
observation. The parameters describing the morphology of
ECM-SIS hydrogel and pure collagen hydrogel were similar
including average fibre diameters (0.105  0.010 vs.
0.114  0.004 mm; p > 0.05), fibre orientation index
(0.51  0.02 vs. 0.52  0.02; p > 0.05), and pore sizes
(0.092  0.012 mm vs. 0.087  0.008 mm; p > 0.05). Further
analysis showed that the porosity of ECM-SIS hydrogel
(88.8  0.7%) was slightly higher than that of collagen
hydrogel (88.0  0.2%; p < 0.05). However, the percentage
difference was less than 1% despite the statistical
significance.
Quantification of growth factors
The presence of FGF-2 and TGF-b1 in the SIS digest was
confirmed, and their contents were 66  26 ng/g and
4  1 ng/g dry SIS, respectively. These values represented
50% of the amount of FGF-2 and 90% of the amount of TGF-
b1 found in the sheet form of ECM-SIS [28].
Cell attachment observation and cell proliferation
assay
After 3 days of cell culture, ACLFs were found attached on
the surface of both the ECM-SIS hydrogel and the pure
collagen hydrogel even without the supply of FBS (0% FBS in
medium; Figures 2A and 2B). Under light microscope and
SEM, cells were observed to attach well to both hydrogels
and manifest similar spindle-shaped appearance (Figure 2).
It was observed that the cells on the ECM-SIS hydrogel
seemed to have reached higher confluency than those on
the collagen hydrogel at this time point regardless of the
concentration of FBS that was applied.
Results of the three-way ANOVA indicated that gel type,
FBS concentration, and culture period all had significant
effects on cell proliferation without significant in-
teractions. At Day 3, the relative fluorescence unit values
from the BrdU assay for the ECM-SIS hydrogel group were
2762  286, 2771  206, and 6848  237 with 0%, 1%, and
10% FBS, respectively. For the pure collagen hydrogel
group, the values were 1985  177, 2109  143, and
5623  28, respectively (Figure 3A). Compared to the
collagen hydrogel, the ECM-SIS hydrogel increased the cell
proliferation by 39%, 31%, and 22% at 0%, 1%, and 10% FBS,
respectively (all p < 0.05), with the most increase being
observed at 0% FBS. At Day 7, the relative fluorescence unitvalues for the SIS hydrogel group were 2798  115,
2872  293, and 12,783  27, whereas those for the pure
collagen hydrogel group were 2317  231, 2392  177, and
11,514  868 at 0%, 1%, and 10% FBS, respectively. At this
time point, the significant difference between the ECM-SIS
hydrogel and the collagen hydrogel was that cell prolifer-
ation at 0% FBSdbut not 1% and 10% FBSdwas still higher in
the former (p < 0.05).
Collagen type I and III gene expressions
For collagen type I mRNA expression, the three-way ANOVA
indicated the SIS hydrogel, FBS concentration, and culture
period had significant effects without significant interac-
tion. At Day 3, relative to the collagen hydrogel, the ECM-
SIS hydrogel significantly increased the mRNA expression of
collagen type I by 150%, 207%, and 100% at 0%, 1%, and 10%
FBS, respectively (p < 0.05; Figure 3B). At Day 7, significant
differences were still observed at 1% and 10% FBS between
the two groups (137% and 100% higher in the ECM-SIS
hydrogel, respectively; p < 0.05).
For collagen type III mRNA expression, the three-way
ANOVA indicated the ECM-SIS hydrogel, FBS concentration,
and culture period had significant effects. At Day 3, the
significant percent increases for the SIS hydrogel group over
the pure collagen gel group were 123% and 132% at 0% and
1% of FBS, respectively (p < 0.05; Figure 3C). At Day 7, no
significant differences in the collagen type III mRNA levels
were found between the two hydrogels at all concentra-
tions of FBS (p > 0.05; Fig. 3C).
Discussion
The results of the current study confirmed our hypothesis
that ECM hydrogel can promote the proliferation and matrix
producing activity of ACLFs, particularly in the context of
low serum concentration that is common when the blood
supply was impaired at the initial stage of ACL rupture.
Among the multiple components derived from the ECM
hydrogels that benefits wound healing and tissue remodel-
ling [17,36], we confirmed the partial preservation of
growth factors in the ECM-SIS hydrogel after processing and
enzyme digestion, i.e., FGF-2 by 50% and TGF-b1 by 90% of
those found in the sheet form of ECM-SIS [28]. In addition,
our results on the mRNA expressions of fibroblasts are
comparable with those of a previous study with cells
seeding on a sheet of SIS bioscaffold [37].
Furthermore, our results showed that the ECM-SIS
hydrogel and a pure collagen hydrogel possessed similar
macro- and micromorphology. The morphometric parame-
ters defining the mechanical properties of a fibrous mate-
rial [38] including fibre diameter, fibre orientation, and
pore size were not significantly different between the two
types of hydrogels except the porosity, for which the ECM-
SIS hydrogel was slightly higher than the collagen hydrogel.
Although it is arguable that the higher porosity may facili-
tate better cell penetration in the ECM-SIS hydrogel, their
overall morphological similarity indicates that the more
superior beneficial effects of the ECM-SIS hydrogel on
cellular activities may not be solely derived from the ar-
chitecture of the material.
Figure 2 Cell attachment on the ECM-SIS hydrogel and pure collagen hydrogel after 3 days of cell culture. (A, B) Images from light
microscopy showing more confluency of cells on the ECM-SIS hydrogel at 0% FBS (100). (C, D). Images from SEM showing similar cell
morphology upon attachment at 10% FBS (1000). (E, F) Images from SEM showing similar cell morphology upon attachment at 10%
FBS (5000). ECMZ extracellular matrix; FBSZ foetal bovine serum; SEMZ scanning electron microscopy; SISZ small intestine
submucosa.
Effects of an ECM hydrogel on ACL fibroblast 119That the ECM-SIS hydrogel had more positive effects on
cell proliferation and matrix gene expressions in compari-
son to those by collagen hydrogel could also be attributed
to the bioactive properties of ECM bioscaffolds. In the
literature, it has been shown that the ECM bioscaffolds
could promote tissue formation and remodelling by limiting
destructive inflammatory responses, recruiting stem cells,
facilitating cell attachment and cell proliferation, as well
as matrix production [36]. ECM hydrogel derived from uri-
nary bladder matrix (UBM) has also been shown to increase
the proliferation of rat aorta smooth muscle cells after 2
days of culture, which is similar to our findings [22].
Although the exact mechanisms are not yet known, it hasbeen suggested that there are multiple bioactive factors
involved in the function of ECM derived products, e.g.,
fibronectin [39], cryptic peptides after digestion, and other
degradation products [40]. Furthermore, a panel of growth
factors has been identified in the ECM-SIS and ECM-UBM
sheets and they may also play a role [28]. In the current
study, we confirmed that FGF-2 and TGF-b1 were retained
in the ECM-SIS hydrogel, albeit in decreased amounts as
compared to those in the ECM-SIS sheet. Nevertheless,
because growth factors have a wide range of functions on
cell activities and are concentration-dependent, it will be
of interest to isolate the function of those that dwell in the
ECM-SIS hydrogel in the future.
Figure 3 Impact of ECM-SIS hydrogel on (A) cell proliferation; (B) collagen type I mRNA expression; and (C) collagen type III mRNA
expression of rat ACLFs as compared with pure collagen hydrogel at different FBS concentrations (nZ 3 for all data sets). Results
are expressed as mean  standard deviation. * Significant difference (p < 0.05). ACLFs Z anterior cruciate ligament fibroblasts;
ECM Z extracellular matrix; FBS Z foetal bovine serum; SIS Z small intestine submucosa.
120 R. Liang et al.The significant improvement in cell proliferation and
mRNA expression of both collagen type I and type III with
ECM-SIS hydrogel at lower concentrations of serum protein
and at early time point are particularly encouraging
because the ruptured ACL lacks ample blood supply [5,41].
In fact, a clinical procedure to improve the ‘healing
response’ of a ruptured ACL is to make microfracture holes
in its femur insertion to introduce blood to encourage he-
matoma formation [9,33]. The procedure has been suc-
cessful in the healing of proximal ACL injuries of patients
older than 40 years. With the recent advance in tissue en-
gineering, more and more studies on healing a transected
ACL with the use of exogenous bioactive factors, such as
hyaluronic acid and FGF-2, have been published [42].
Others have used bioscaffolds in combination with platelet-
rich plasma or hydrogels [25,43,44]. Thus, ECM-SIS hydrogel
could be another promising agent as it could facilitate cell
attachment and growth as well as active matrix production
to bridge the gap early and provide the needed structural
support for healing to proceed.It is noticeable that the positive effect of ECM-SIS
hydrogel on the collagen type I mRNA expression per-
sisted until Day 7 even at high levels of serum proteins,
indicating that even at the later stage of ACL healing, when
the blood supply to the ligament is restored to some extent,
the ECM-SIS gel may still assist in the healing by improving
collagen type I production, which is the major matrix
molecule to maintain ligament structure and function.
A limitation to the current study is that the ACLFs were
those isolated from normal ACLs, instead of healing ACL.
Whether the positive effects of the SIS hydrogel would
remain on fibroblasts in the ruptured ACL will be confirmed
in follow-up studies. Nevertheless, it is necessary to
perform the current study in order to clearly demonstrate
that the ECM-SIS hydrogel can indeed facilitate the activ-
ities of ACLFs, which are intrinsically low in their ability to
proliferate and to produce matrix in comparison to those
from the extra-articular ligaments. In addition, ECM ma-
terials derived from animals are not autologous like
platelet-rich plasma and may induce host foreign body
Effects of an ECM hydrogel on ACL fibroblast 121reactions. However, our procedures have diminished a-Gal
epitopes and followed strict standardised decellularisation
that largely eliminated the risk. Considering that porcine
ECMs are Food and Drug Administration approved and are
used clinically, we believe that the ECM-SIS hydrogel could
also be translated to clinical applications to promote the
healing of ligaments and tendons.
In conclusion, the ECM-SIS hydrogel has demonstrated
superior properties in promoting ACLF proliferation and
matrix production. As such, the ECM-SIS hydrogel has the
potential therapeutic value to facilitate ACL healing,
particularly at the early stage of the injury. In the future,
the exact mechanisms will be explored and its positive ef-
fects further verified in vivo.
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